Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022

SELL
$118.07 - $194.18 $77,926 - $128,158
-660 Reduced 21.11%
2,467 $292,000
Q2 2022

Aug 04, 2022

BUY
$117.13 - $176.59 $366,265 - $552,196
3,127 New
3,127 $513,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Jackson Creek Investment Advisors LLC Portfolio

Follow Jackson Creek Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson Creek Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jackson Creek Investment Advisors LLC with notifications on news.